164 results on '"Gao, Yingtang"'
Search Results
2. Identification of a bile acid and bile salt metabolism-related lncRNA signature for predicting prognosis and treatment response in hepatocellular carcinoma
3. ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation
4. Influencing factors and predictive model of postoperative infection in patients with primary hepatic carcinoma
5. Potential Role of Hydrogels in Stem Cell Culture and Hepatocyte Differentiation
6. A novel nested gene Aff3ir participates in vascular remodeling by enhancing endothelial cell differentiation in mice
7. Deficiency of voltage-gated proton channel Hv1 aggravates ovalbumin-induced allergic lung asthma in mice
8. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway
9. A novel nested geneAff3irparticipates in vascular remodelling by enhancing endothelial cell differentiation in mice
10. SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance
11. Three-dimensional hydrogel culture conditions promote the differentiation of human induced pluripotent stem cells into hepatocytes
12. A novel nested gene Aff3ir participates in vascular remodeling by enhancing endothelial cell differentiation in mice
13. Biomarkers of oxidation stress, inflammation, necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure
14. Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells
15. Low density lipoprotein receptor class A domain containing 4 (LDLRAD4) promotes tumorigenesis of hepatic cancer cells
16. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma
17. The subtype CD200-positive, chorionic mesenchymal stem cells from the placenta promote regeneration of human hepatocytes
18. pH-responsive Functionalized Extracellular Vesicles as Targeted Doxorubicin Delivery Vehicles for the Treatment of Hepatocarcinoma
19. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
20. Mice lacking the proton channel Hv1 exhibit sex-specific differences in glucose homeostasis
21. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles
22. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma
23. Optimized culture methods for isolating small extracellular vesicles derived from human induced pluripotent stem cells
24. X-box binding protein 1–mediated COL4A1s secretion regulates communication between vascular smooth muscle and stem/progenitor cells
25. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma
26. Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma
27. Loss of voltage-gated proton channel Hv1 leads to diet-induced obesity in mice
28. Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin
29. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis
30. The state of T cells before cryopreservation: Effects on post-thaw proliferation and function
31. Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway
32. Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
33. Metabolic perturbation of epigenome by inhibiting S-adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells
34. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker
35. A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease
36. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
37. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma
38. Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway.
39. Overexpression of Squamous Cell Carcinoma Antigen 1 Is Associated with the Onset and Progression of Human Hepatocellular Carcinoma
40. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma
41. Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma
42. Exploring the Functional Disorder and Corresponding Key Transcription Factors in Intraductal Papillary Mucinous Neoplasms Progression
43. Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma.
44. The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease.
45. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma
46. Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
47. Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
48. Micropatterned designs of thermoresponsive surfaces for modulating cell behaviors
49. Fabrication of polystyrene microscale porous substrate and its effects on HL‐7702 cells behaviors
50. Correlation of prognosis with the gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.